triple glp 1 agonist retatrutide ly3437943 glp-1 gip glucagon mechanism Beyond -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based History of glucagon-like peptide-1 receptor
Pay in 4 interest-free payments of $7.26 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

























:max_bytes(150000):strip_icc()/remove-cigarette-stains-and-odors-2147070-02-e731f2a333d44bc29e3f66e350e0257b.jpg)



